The clinical significance and biological function of interferon regulatory factor 1 in cholangiocarcinoma

Peiqi Wan1, Junhong Zhang2, Qiang Du3

  • 1Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15213, USA; Department of infectious diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, PR China.

Insights

Interferon regulatory factor 1 (IRF1) is downregulated in cholangiocarcinoma, correlating with poor prognosis. Restoring IRF1 suppresses tumor growth, migration, and invasion, supporting its role as a tumor suppressor.

Area of Science:

  • Oncology
  • Molecular Biology
  • Hepatobiliary Surgery

Background:

  • Interferon regulatory factor 1 (IRF1) is implicated as a tumor suppressor in various human cancers.
  • The specific role and clinical significance of IRF1 in cholangiocarcinoma remain largely uncharacterized.

Purpose of the Study:

  • To investigate the expression levels, clinical significance, and biological functions of IRF1 in cholangiocarcinoma.

Main Methods:

  • Quantitative analysis of IRF1 mRNA and protein expression in cholangiocarcinoma tissues and cell lines versus normal controls.
  • Correlation analysis between IRF1 expression and clinicopathological parameters.
  • Functional assays to assess the impact of IRF1 up-regulation on cholangiocarcinoma cell proliferation, migration, invasion, cell cycle, and apoptosis.

Main Results:

  • IRF1 mRNA and protein expression were significantly decreased in cholangiocarcinoma tissues and cell lines.
  • Low IRF1 protein expression correlated with advanced tumor stage, larger tumor size, vascular invasion, and metastasis.
  • IRF1 served as an independent poor prognostic factor for cholangiocarcinoma patients.
  • IRF1 up-regulation inhibited cholangiocarcinoma cell proliferation, migration, and invasion, and induced cell cycle arrest without affecting apoptosis.

Conclusions:

  • IRF1 is frequently downregulated in cholangiocarcinoma, associated with aggressive disease and poor outcomes.
  • IRF1 functions as a tumor suppressor by inhibiting proliferation, migration, invasion, and cell cycle progression in cholangiocarcinoma.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.7K